28 September is the International Day for Universal Access to Information.
We make sure to update people as the #LONGEVITYproject moves. Including our quarterly newsletter with news and stories they may have missed via our social media platforms:
www.liverpool.ac.uk/celt-global-...
#IDUAI26
We make sure to update people as the #LONGEVITYproject moves. Including our quarterly newsletter with news and stories they may have missed via our social media platforms:
www.liverpool.ac.uk/celt-global-...
#IDUAI26
September 28, 2026 at 11:59 AM
28 September is the International Day for Universal Access to Information.
We make sure to update people as the #LONGEVITYproject moves. Including our quarterly newsletter with news and stories they may have missed via our social media platforms:
www.liverpool.ac.uk/celt-global-...
#IDUAI26
We make sure to update people as the #LONGEVITYproject moves. Including our quarterly newsletter with news and stories they may have missed via our social media platforms:
www.liverpool.ac.uk/celt-global-...
#IDUAI26
We're looking forward to this next month.
CELT are presenting and some #LONGEVITYproject work, funded by @unitaid.bsky.social, is being represented as well.
If you're there, please find us to say hi.
CELT are presenting and some #LONGEVITYproject work, funded by @unitaid.bsky.social, is being represented as well.
If you're there, please find us to say hi.
Next stop: Amsterdam!
Counting down the days to the 26th International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs!
Topics: #pandemic preparedness, #druginteraction, #LongActing for #HCV, #CMVTherapy, and more!
🔗 amededu.co/4hTUPgN
#IDSky #MedSky #ANTIVIRALPK
Counting down the days to the 26th International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs!
Topics: #pandemic preparedness, #druginteraction, #LongActing for #HCV, #CMVTherapy, and more!
🔗 amededu.co/4hTUPgN
#IDSky #MedSky #ANTIVIRALPK
August 15, 2025 at 11:24 AM
We're looking forward to this next month.
CELT are presenting and some #LONGEVITYproject work, funded by @unitaid.bsky.social, is being represented as well.
If you're there, please find us to say hi.
CELT are presenting and some #LONGEVITYproject work, funded by @unitaid.bsky.social, is being represented as well.
If you're there, please find us to say hi.
CELT's #LONGEVITYproject research, funded by @unitaid.bsky.social, includes long-acting tuberculosis preventative therapies for patients in low- and middle- income countries, to help people avoid contracting TB disease.
Find out more about LONGEVITY's TB work: www.liverpool.ac.uk/centre-of-ex...
Find out more about LONGEVITY's TB work: www.liverpool.ac.uk/centre-of-ex...
August 6, 2025 at 11:26 AM
CELT's #LONGEVITYproject research, funded by @unitaid.bsky.social, includes long-acting tuberculosis preventative therapies for patients in low- and middle- income countries, to help people avoid contracting TB disease.
Find out more about LONGEVITY's TB work: www.liverpool.ac.uk/centre-of-ex...
Find out more about LONGEVITY's TB work: www.liverpool.ac.uk/centre-of-ex...
Dr Arshad's poster 'Preclinical pharmacokinetic assessment of a long-acting solid injectable for hepatitis C virus' is part of the #LONGEVITYproject, funded by @unitaid.bsky.social.
We connected with many long-acting scientists and we're looking forward to continuing those conversations.
#CROI2025
We connected with many long-acting scientists and we're looking forward to continuing those conversations.
#CROI2025
March 18, 2025 at 1:12 PM
Dr Arshad's poster 'Preclinical pharmacokinetic assessment of a long-acting solid injectable for hepatitis C virus' is part of the #LONGEVITYproject, funded by @unitaid.bsky.social.
We connected with many long-acting scientists and we're looking forward to continuing those conversations.
#CROI2025
We connected with many long-acting scientists and we're looking forward to continuing those conversations.
#CROI2025
Are you subscribed to our #LONGEVITYproject newsletter?
A quarterly update of the international consortium work (funded by @unitaid.bsky.social) to bring long-acting treatments or preventatives to patients with tuberculosis, hepatitis C virus and malaria in LMICs
www.liverpool.ac.uk/celt-global-...
A quarterly update of the international consortium work (funded by @unitaid.bsky.social) to bring long-acting treatments or preventatives to patients with tuberculosis, hepatitis C virus and malaria in LMICs
www.liverpool.ac.uk/celt-global-...
January 21, 2026 at 12:02 PM
Are you subscribed to our #LONGEVITYproject newsletter?
A quarterly update of the international consortium work (funded by @unitaid.bsky.social) to bring long-acting treatments or preventatives to patients with tuberculosis, hepatitis C virus and malaria in LMICs
www.liverpool.ac.uk/celt-global-...
A quarterly update of the international consortium work (funded by @unitaid.bsky.social) to bring long-acting treatments or preventatives to patients with tuberculosis, hepatitis C virus and malaria in LMICs
www.liverpool.ac.uk/celt-global-...
17 September is #InternationalMicroorganismDay and @who.int's #PatientSafetyDay
We're highlighting #LONGEVITYproject. Explore the impact of the project diseases (HCV, malaria and TB) and our long-acting options work to keep LMIC patients safe from them.
www.liverpool.ac.uk/centre-of-ex...
We're highlighting #LONGEVITYproject. Explore the impact of the project diseases (HCV, malaria and TB) and our long-acting options work to keep LMIC patients safe from them.
www.liverpool.ac.uk/centre-of-ex...
September 17, 2025 at 11:49 AM
17 September is #InternationalMicroorganismDay and @who.int's #PatientSafetyDay
We're highlighting #LONGEVITYproject. Explore the impact of the project diseases (HCV, malaria and TB) and our long-acting options work to keep LMIC patients safe from them.
www.liverpool.ac.uk/centre-of-ex...
We're highlighting #LONGEVITYproject. Explore the impact of the project diseases (HCV, malaria and TB) and our long-acting options work to keep LMIC patients safe from them.
www.liverpool.ac.uk/centre-of-ex...
17-23 November is @worldhepalliance.bsky.social #WorldHepatitisTestingWeek.
We wrote a blog on hepatitis testing as a global issue
The #LONGEVITYproject, is working on a one-shot-cure for HCV to provide patients in LMICs treatment at diagnosis
www.liverpool.ac.uk/centre-of-ex...
@unitaid.bsky.social
We wrote a blog on hepatitis testing as a global issue
The #LONGEVITYproject, is working on a one-shot-cure for HCV to provide patients in LMICs treatment at diagnosis
www.liverpool.ac.uk/centre-of-ex...
@unitaid.bsky.social
November 19, 2025 at 12:19 PM
17-23 November is @worldhepalliance.bsky.social #WorldHepatitisTestingWeek.
We wrote a blog on hepatitis testing as a global issue
The #LONGEVITYproject, is working on a one-shot-cure for HCV to provide patients in LMICs treatment at diagnosis
www.liverpool.ac.uk/centre-of-ex...
@unitaid.bsky.social
We wrote a blog on hepatitis testing as a global issue
The #LONGEVITYproject, is working on a one-shot-cure for HCV to provide patients in LMICs treatment at diagnosis
www.liverpool.ac.uk/centre-of-ex...
@unitaid.bsky.social
Read a recent report from @treatmentactiongroup.org, bringing together #LONGEVITYproject low- and middle- income countries' (LMICs) hepatitis C virus community and civil society engagement research, funded by global health agency @unitaid.bsky.social.
www.treatmentactiongroup.org/publication/...
www.treatmentactiongroup.org/publication/...
Just one of the findings from our new publication that discusses findings from two surveys on potential long-acting therapies for hepatitis c virus (HCV) currently being developed by the LONGEVITY consortium, funded by Unitaid. www.treatmentactiongroup.org/publication/...
June 4, 2025 at 10:59 AM
Read a recent report from @treatmentactiongroup.org, bringing together #LONGEVITYproject low- and middle- income countries' (LMICs) hepatitis C virus community and civil society engagement research, funded by global health agency @unitaid.bsky.social.
www.treatmentactiongroup.org/publication/...
www.treatmentactiongroup.org/publication/...
In this piece, Dr Marcia Vermeulen tells us about her research journey including work with the #LONGEVITYproject on our tuberculosis community engagement work.
As it was International Women's Day yesterday we're sharing it again for you.
www.liverpool.ac.uk/celt-global-...
@unitaid.bsky.social
As it was International Women's Day yesterday we're sharing it again for you.
www.liverpool.ac.uk/celt-global-...
@unitaid.bsky.social
March 9, 2026 at 4:15 PM
In this piece, Dr Marcia Vermeulen tells us about her research journey including work with the #LONGEVITYproject on our tuberculosis community engagement work.
As it was International Women's Day yesterday we're sharing it again for you.
www.liverpool.ac.uk/celt-global-...
@unitaid.bsky.social
As it was International Women's Day yesterday we're sharing it again for you.
www.liverpool.ac.uk/celt-global-...
@unitaid.bsky.social
#LONGEVITYproject, funded by global health agency @unitaid.bsky.social, is an ambitious one that hopes to be part of eradicating devastating diseases in low- and middle- income countries. Patient and provider involvement in our work makes sure what we hope a solution is and what patients want align.
May 30, 2025 at 8:50 AM
#LONGEVITYproject, funded by global health agency @unitaid.bsky.social, is an ambitious one that hopes to be part of eradicating devastating diseases in low- and middle- income countries. Patient and provider involvement in our work makes sure what we hope a solution is and what patients want align.
28 July is #WorldHepatitisDay.
#LONGEVITYproject, funded by @unitaid.bsky.social, spent time at CROI showing proof-of-concept of a solid long-acting injectable hepatitis C virus treatment with @jhu.edu that could offer a one-shot-cure option for HCV.
Read more: www.liverpool.ac.uk/centre-of-ex...
#LONGEVITYproject, funded by @unitaid.bsky.social, spent time at CROI showing proof-of-concept of a solid long-acting injectable hepatitis C virus treatment with @jhu.edu that could offer a one-shot-cure option for HCV.
Read more: www.liverpool.ac.uk/centre-of-ex...
July 28, 2025 at 11:54 AM
28 July is #WorldHepatitisDay.
#LONGEVITYproject, funded by @unitaid.bsky.social, spent time at CROI showing proof-of-concept of a solid long-acting injectable hepatitis C virus treatment with @jhu.edu that could offer a one-shot-cure option for HCV.
Read more: www.liverpool.ac.uk/centre-of-ex...
#LONGEVITYproject, funded by @unitaid.bsky.social, spent time at CROI showing proof-of-concept of a solid long-acting injectable hepatitis C virus treatment with @jhu.edu that could offer a one-shot-cure option for HCV.
Read more: www.liverpool.ac.uk/centre-of-ex...
Still wondering what the #LONGEVITYproject is?
We have a less than 2 and a half minutes video explaining our work creating long-acting therapeutics for HCV, malaria and TB for people in LMICs: youtu.be/wxWAcUNqxTQ
LONGEVITY is funded by global health agency @unitaid.bsky.social.
We have a less than 2 and a half minutes video explaining our work creating long-acting therapeutics for HCV, malaria and TB for people in LMICs: youtu.be/wxWAcUNqxTQ
LONGEVITY is funded by global health agency @unitaid.bsky.social.
The LONGEVITY Project
YouTube video by CELT Liverpool
youtu.be
July 6, 2026 at 11:19 AM
Still wondering what the #LONGEVITYproject is?
We have a less than 2 and a half minutes video explaining our work creating long-acting therapeutics for HCV, malaria and TB for people in LMICs: youtu.be/wxWAcUNqxTQ
LONGEVITY is funded by global health agency @unitaid.bsky.social.
We have a less than 2 and a half minutes video explaining our work creating long-acting therapeutics for HCV, malaria and TB for people in LMICs: youtu.be/wxWAcUNqxTQ
LONGEVITY is funded by global health agency @unitaid.bsky.social.
The International Journal of Tuberculosis and Lung Disease has published #LONGEVITYproject research
@unmc.bsky.social, @treatmentactiongroup.org & @cidri-africa.bsky.social surveyed 400 patients, 75% wanted to try long-acting TB therapeutics
www.liverpool.ac.uk/centre-of-ex...
@unitaid.bsky.social
@unmc.bsky.social, @treatmentactiongroup.org & @cidri-africa.bsky.social surveyed 400 patients, 75% wanted to try long-acting TB therapeutics
www.liverpool.ac.uk/centre-of-ex...
@unitaid.bsky.social
May 14, 2025 at 2:19 PM
The International Journal of Tuberculosis and Lung Disease has published #LONGEVITYproject research
@unmc.bsky.social, @treatmentactiongroup.org & @cidri-africa.bsky.social surveyed 400 patients, 75% wanted to try long-acting TB therapeutics
www.liverpool.ac.uk/centre-of-ex...
@unitaid.bsky.social
@unmc.bsky.social, @treatmentactiongroup.org & @cidri-africa.bsky.social surveyed 400 patients, 75% wanted to try long-acting TB therapeutics
www.liverpool.ac.uk/centre-of-ex...
@unitaid.bsky.social
🧵1/4
We're trying to make sure our work on the #LONGEVITYproject is as transparent as possible.
Funded by @unitaid.bsky.social, we've created a breakdown of what the work for each disease looks like.
We hope an accessible explanation will help show the journey of each disease.
We're trying to make sure our work on the #LONGEVITYproject is as transparent as possible.
Funded by @unitaid.bsky.social, we've created a breakdown of what the work for each disease looks like.
We hope an accessible explanation will help show the journey of each disease.
February 6, 2026 at 12:45 PM
🧵1/4
We're trying to make sure our work on the #LONGEVITYproject is as transparent as possible.
Funded by @unitaid.bsky.social, we've created a breakdown of what the work for each disease looks like.
We hope an accessible explanation will help show the journey of each disease.
We're trying to make sure our work on the #LONGEVITYproject is as transparent as possible.
Funded by @unitaid.bsky.social, we've created a breakdown of what the work for each disease looks like.
We hope an accessible explanation will help show the journey of each disease.
Are you signed up to the quarterly #LONGEVITYproject newsletter?
The international consortium aim to bring long-acting preventatives/treatments to HCV, malaria and TB patients in LMICs, where these diseases have the biggest impact.
Sign up: www.liverpool.ac.uk/centre-of-ex...
@unitaid.bsky.social
The international consortium aim to bring long-acting preventatives/treatments to HCV, malaria and TB patients in LMICs, where these diseases have the biggest impact.
Sign up: www.liverpool.ac.uk/centre-of-ex...
@unitaid.bsky.social
November 25, 2025 at 1:02 PM
Are you signed up to the quarterly #LONGEVITYproject newsletter?
The international consortium aim to bring long-acting preventatives/treatments to HCV, malaria and TB patients in LMICs, where these diseases have the biggest impact.
Sign up: www.liverpool.ac.uk/centre-of-ex...
@unitaid.bsky.social
The international consortium aim to bring long-acting preventatives/treatments to HCV, malaria and TB patients in LMICs, where these diseases have the biggest impact.
Sign up: www.liverpool.ac.uk/centre-of-ex...
@unitaid.bsky.social
Are you signed up the #LONGEVITYproject newsletter?
Every quarter we send an email updating you with news from the last few months, and let you know about upcoming LONGEVITY relevant events and opportunities.
You can subscribe via the link: www.liverpool.ac.uk/celt-global-...
@unitaid.bsky.social
Every quarter we send an email updating you with news from the last few months, and let you know about upcoming LONGEVITY relevant events and opportunities.
You can subscribe via the link: www.liverpool.ac.uk/celt-global-...
@unitaid.bsky.social
February 17, 2026 at 2:58 PM
Are you signed up the #LONGEVITYproject newsletter?
Every quarter we send an email updating you with news from the last few months, and let you know about upcoming LONGEVITY relevant events and opportunities.
You can subscribe via the link: www.liverpool.ac.uk/celt-global-...
@unitaid.bsky.social
Every quarter we send an email updating you with news from the last few months, and let you know about upcoming LONGEVITY relevant events and opportunities.
You can subscribe via the link: www.liverpool.ac.uk/celt-global-...
@unitaid.bsky.social
Next week is our quarterly #LONGEVITYproject newsletter.
This quarter includes:
- Work from partners @treatmentactiongroup.org and CHAI.
- Recent hepatitis C virus proof of concept news
- Community of Practice meeting highlights.
Subscribe: www.liverpool.ac.uk/centre-of-ex...
@unitaid.bsky.social
This quarter includes:
- Work from partners @treatmentactiongroup.org and CHAI.
- Recent hepatitis C virus proof of concept news
- Community of Practice meeting highlights.
Subscribe: www.liverpool.ac.uk/centre-of-ex...
@unitaid.bsky.social
September 24, 2025 at 12:23 PM
Next week is our quarterly #LONGEVITYproject newsletter.
This quarter includes:
- Work from partners @treatmentactiongroup.org and CHAI.
- Recent hepatitis C virus proof of concept news
- Community of Practice meeting highlights.
Subscribe: www.liverpool.ac.uk/centre-of-ex...
@unitaid.bsky.social
This quarter includes:
- Work from partners @treatmentactiongroup.org and CHAI.
- Recent hepatitis C virus proof of concept news
- Community of Practice meeting highlights.
Subscribe: www.liverpool.ac.uk/centre-of-ex...
@unitaid.bsky.social
Are you subscribed to our quarterly #LONGEVITYproject newsletter?
We update LONGEVITY news, opportunities and global events.
LONGEVITY, funded by @unitaid.bsky.social, is working to create long-acting malaria, TB and HCV medicines for patients in LMICs.
Sign up: www.liverpool.ac.uk/centre-of-ex...
We update LONGEVITY news, opportunities and global events.
LONGEVITY, funded by @unitaid.bsky.social, is working to create long-acting malaria, TB and HCV medicines for patients in LMICs.
Sign up: www.liverpool.ac.uk/centre-of-ex...
October 23, 2025 at 11:53 AM
Are you subscribed to our quarterly #LONGEVITYproject newsletter?
We update LONGEVITY news, opportunities and global events.
LONGEVITY, funded by @unitaid.bsky.social, is working to create long-acting malaria, TB and HCV medicines for patients in LMICs.
Sign up: www.liverpool.ac.uk/centre-of-ex...
We update LONGEVITY news, opportunities and global events.
LONGEVITY, funded by @unitaid.bsky.social, is working to create long-acting malaria, TB and HCV medicines for patients in LMICs.
Sign up: www.liverpool.ac.uk/centre-of-ex...
19 April is #NationalHepatitisTestingDay.
#LONGEVITYproject, funded by @unitaid.bsky.social, is working to create long-acting versions of existing #HCV medicines for patients in LMICs.
Knowing our hepatitis status is a key global message.
Read more:
www.liverpool.ac.uk/centre-of-ex...
#HepAware
#LONGEVITYproject, funded by @unitaid.bsky.social, is working to create long-acting versions of existing #HCV medicines for patients in LMICs.
Knowing our hepatitis status is a key global message.
Read more:
www.liverpool.ac.uk/centre-of-ex...
#HepAware
May 19, 2025 at 10:57 AM
19 April is #NationalHepatitisTestingDay.
#LONGEVITYproject, funded by @unitaid.bsky.social, is working to create long-acting versions of existing #HCV medicines for patients in LMICs.
Knowing our hepatitis status is a key global message.
Read more:
www.liverpool.ac.uk/centre-of-ex...
#HepAware
#LONGEVITYproject, funded by @unitaid.bsky.social, is working to create long-acting versions of existing #HCV medicines for patients in LMICs.
Knowing our hepatitis status is a key global message.
Read more:
www.liverpool.ac.uk/centre-of-ex...
#HepAware
We send a quarterly newsletter about recent #LONGEVITYproject work.
We're working to create long-acting preventive options for malaria and TB, and a one-shot cure for HCV, which will be prioritised to people living in LMICs with the highest disease burden.
www.liverpool.ac.uk/celt-global-...
We're working to create long-acting preventive options for malaria and TB, and a one-shot cure for HCV, which will be prioritised to people living in LMICs with the highest disease burden.
www.liverpool.ac.uk/celt-global-...
August 17, 2026 at 11:30 AM
We send a quarterly newsletter about recent #LONGEVITYproject work.
We're working to create long-acting preventive options for malaria and TB, and a one-shot cure for HCV, which will be prioritised to people living in LMICs with the highest disease burden.
www.liverpool.ac.uk/celt-global-...
We're working to create long-acting preventive options for malaria and TB, and a one-shot cure for HCV, which will be prioritised to people living in LMICs with the highest disease burden.
www.liverpool.ac.uk/celt-global-...
We send quarterly newsletters for the #LONGEVITYproject, funded by @unitaid.bsky.social.
The newsletter lets you know the news from our international consortium, any LONGEVITY related opportunities and upcoming events where our work will be presented.
Subscribe: www.liverpool.ac.uk/centre-of-ex...
The newsletter lets you know the news from our international consortium, any LONGEVITY related opportunities and upcoming events where our work will be presented.
Subscribe: www.liverpool.ac.uk/centre-of-ex...
July 31, 2025 at 11:22 AM
We send quarterly newsletters for the #LONGEVITYproject, funded by @unitaid.bsky.social.
The newsletter lets you know the news from our international consortium, any LONGEVITY related opportunities and upcoming events where our work will be presented.
Subscribe: www.liverpool.ac.uk/centre-of-ex...
The newsletter lets you know the news from our international consortium, any LONGEVITY related opportunities and upcoming events where our work will be presented.
Subscribe: www.liverpool.ac.uk/centre-of-ex...
#LONGEVITYproject partner @treatmentactiongroup.org illustrated a #WorldHepatitisDay storyboard
It's Sibusiso Dlamini's HCV experience, which is the story of how important accessible care is for HCV diagnosis, treatment and aftercare
www.treatmentactiongroup.org/publication/...
@unitaid.bsky.social
It's Sibusiso Dlamini's HCV experience, which is the story of how important accessible care is for HCV diagnosis, treatment and aftercare
www.treatmentactiongroup.org/publication/...
@unitaid.bsky.social
July 29, 2025 at 11:19 AM
#LONGEVITYproject partner @treatmentactiongroup.org illustrated a #WorldHepatitisDay storyboard
It's Sibusiso Dlamini's HCV experience, which is the story of how important accessible care is for HCV diagnosis, treatment and aftercare
www.treatmentactiongroup.org/publication/...
@unitaid.bsky.social
It's Sibusiso Dlamini's HCV experience, which is the story of how important accessible care is for HCV diagnosis, treatment and aftercare
www.treatmentactiongroup.org/publication/...
@unitaid.bsky.social
The quarterly #LONGEVITYproject newsletter is out next week.
This issue is packed with exciting news and opportunities.
If you're not subscribed, you can do so via the 'Sign up to our newsletter' form at the bottom of any LONGEVITY page:
👉 www.liverpool.ac.uk/longevity/
@unitaid.bsky.social
This issue is packed with exciting news and opportunities.
If you're not subscribed, you can do so via the 'Sign up to our newsletter' form at the bottom of any LONGEVITY page:
👉 www.liverpool.ac.uk/longevity/
@unitaid.bsky.social
March 25, 2025 at 12:23 PM
The quarterly #LONGEVITYproject newsletter is out next week.
This issue is packed with exciting news and opportunities.
If you're not subscribed, you can do so via the 'Sign up to our newsletter' form at the bottom of any LONGEVITY page:
👉 www.liverpool.ac.uk/longevity/
@unitaid.bsky.social
This issue is packed with exciting news and opportunities.
If you're not subscribed, you can do so via the 'Sign up to our newsletter' form at the bottom of any LONGEVITY page:
👉 www.liverpool.ac.uk/longevity/
@unitaid.bsky.social
For @unesco.org's International Day of Women and Girls in Science, we spoke to Dr Marcia Vermeulen from University of Cape Town, who oversaw #LONGEVITYproject tuberculosis community engagement work with patients and providers: www.liverpool.ac.uk/celt-global-...
#February11
@unitaid.bsky.social
#February11
@unitaid.bsky.social
February 11, 2026 at 2:38 PM
For @unesco.org's International Day of Women and Girls in Science, we spoke to Dr Marcia Vermeulen from University of Cape Town, who oversaw #LONGEVITYproject tuberculosis community engagement work with patients and providers: www.liverpool.ac.uk/celt-global-...
#February11
@unitaid.bsky.social
#February11
@unitaid.bsky.social
In May, the @treatmentactiongroup.org(TAG) held a 90 minute webinar presenting all the current community and civil society engagement work from the #LONGEVITYproject.
Read all about it and find links to slides and a recording via the link: www.liverpool.ac.uk/centre-of-ex...
Read all about it and find links to slides and a recording via the link: www.liverpool.ac.uk/centre-of-ex...
June 30, 2025 at 3:53 PM
In May, the @treatmentactiongroup.org(TAG) held a 90 minute webinar presenting all the current community and civil society engagement work from the #LONGEVITYproject.
Read all about it and find links to slides and a recording via the link: www.liverpool.ac.uk/centre-of-ex...
Read all about it and find links to slides and a recording via the link: www.liverpool.ac.uk/centre-of-ex...